Explore the role of enzymes in breaking down β-1,2-glucans and advancing our understanding of carbohydrate metabolism.

The problem of how to exploit the vast potential of complex glycans in drug development involves overcoming fundamental challenges to clarify important structure– activity relationships.

Company to discuss glycan-targeting ADC platform during BIO International Convention 2025 NEW TAIPEI CITY, Taiwan, June 12, ...

It also prevents many novel therapies from making it through the critical Phase I stage of clinical trials, where drug safety is assessed. kyron.bio’s solution: Precision control over glycans to ...

The sea cucumber has been found to naturally produce a sugary compound that inhibits an enzyme instrumental in facilitating ...

A sugar in sea cucumbers may block a cancer-linked enzyme without affecting blood clotting or requiring pig-based drugs.

Advanced mass spectrometry techniques are now enabling more precise glycan analysis, improving therapeutic development and manufacturing processes. This webinar highlights an electron-activated ...